Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett esophagus.

John A Bonino1, Prateek Sharma

  • 1Division of Gastroenterology and Hepatology, University of Kansas School of Medicine and Veterans Affairs Medical Center, Kansas City, Missouri 64128-2295, USA.

Current Opinion in Gastroenterology
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of response to neoadjuvant chemotherapy in technically unresectable moderately advanced oral cavity cancers.

Journal of cancer research and therapeutics·2024
Same author

Assessment of quality of life in head and neck cancer patients visiting the Palliative Care outpatient department in a tertiary care oncology centre in India.

Indian journal of cancer·2024
Same author

Therapeutic potential of transient receptor potential (TRP) channels in psychiatric disorders.

Journal of neural transmission (Vienna, Austria : 1996)·2024
Same author

Endoscopic submucosal dissection and endoscopic mucosal resection for Barrett's-associated neoplasia: a systematic review and meta-analysis of the published literature.

Endoscopy·2024
Same author

Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases.

Pharmacological reports : PR·2024
Same author

Alteration of gastric microbiota in Helicobacter pylori - infected individuals suffering from gastroesophageal reflux disease, duodenal ulcer, and gastritis.

Indian journal of pathology & microbiology·2024
Same journal

Neuroendocrine tumors of the stomach and duodenum: evolving classification, endoscopic management, and surveillance.

Current opinion in gastroenterology·2026
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
See all related articles

Recent advancements focus on identifying individuals at risk for esophageal adenocarcinoma by understanding Barrett esophagus. Key developments include refined screening, surveillance, and treatment strategies to reduce mortality.

Area of Science:

  • Gastroenterology
  • Oncology
  • Epidemiology

Background:

  • Barrett esophagus is a precursor to esophageal adenocarcinoma, a condition with significant mortality.
  • Understanding risk factors and improving early detection are crucial for reducing esophageal cancer rates.

Purpose of the Study:

  • To summarize recent advancements in the epidemiology, screening, pathogenesis, surveillance, and treatment of Barrett esophagus.
  • To highlight key findings from the past year's literature on managing this condition.

Main Methods:

  • Review of current literature on Barrett esophagus.
  • Analysis of new technologies and risk factor identification.
  • Evaluation of emerging treatment strategies and diagnostic tools.

Related Experiment Videos

Main Results:

  • Identification of increased risk factors including age, heartburn, segment length, and male sex.
  • Emergence of new screening technologies like smaller endoscopes and high-magnification endoscopy.
  • Ongoing debate regarding the efficacy of antireflux surgery and continued revelation of chromosomal abnormalities.

Conclusions:

  • Significant progress has been made in diagnosing, surveilling, and treating Barrett esophagus.
  • Physicians must stay informed about these developments to effectively manage patients and mitigate esophageal adenocarcinoma risk.